StockDuty ← Dashboard Aug 18, 2026 07:45 PM ET
CatalystCorporate

AMYLYX STOCK SOARS AFTER ITS GLP-1 BLOCKER CUT DANGEROUS LOW-BLOOD-SUGAR EVENTS IN TRIAL - QZ

GLP-1 trial data cut hypoglycemia events, driving Amylyx stock surge.

What changed
Why it matters
GLP-1 trial data cut hypoglycemia events, driving Amylyx stock surge.
Sources
qz
Related signals
FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →SCOTT BESSENT SURPRISE BOND BUYBACK SPARKS A SILVER RALLY . IS IT TOO LATE TO BUY IN ? →